Willow Biosciences Inc (FRA:3D7)
€ 0.0725 0 (0%) Market Cap: 10.37 Mil Enterprise Value: 10.64 Mil PE Ratio: 0 PB Ratio: 10.00 GF Score: 33/100

Willow Biosciences Inc at Emerging Growth Conference Transcript

Jun 14, 2023 / 02:15PM GMT
Release Date Price: €0.0775 (+0.65%)
Ana Berry
Berry Media, Inc - Media

Welcome back, everyone. Next up, we have Willow Biosciences. It trades on the OTCQB under the symbol CANSF and on the TSX under the symbol WLLW and is a leading biotech company that develops precision fermentation processes for sustainable and cost-effective production of natural functional ingredients used in consumer care, food and beverage, and pharmaceutical products. Using their future-grown engineering platform, they can rapidly develop bio-based industrial processes to replace unsustainable, higher-cost extracted, and synthetic ingredients.

Today, we have with us Willow's CEO, Chris Savile. Now, Willow Biosciences' CEO has close to 20 years' experience in science, commercial, and operations roles in biotech. He is a highly experienced scientific and business leader, focused on the scale up and commercialization of bio-based processes for specialty chemicals, food and beverage, and pharma. Dr. Savile has acted as a technical and commercial leader on several large R&D programs that led to commercial processes. Prior to Willow, Dr. Savile worked at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot